Zimmer Biomet is committed to good corporate governance and believes that an attentive, performing Board is a tangible competitive advantage. Within this section of Zimmer Biomet's website, you will find the following information on:

Principles

Code of Business Conduct and Ethics PDF
Code of Ethics for CEO and Senior Financial Officers PDF
Board Policy on Ratification of Independent Registered Public Accounting Firm PDF
Board Policy on Stockholder Rights Plans PDF
Corporate Governance Guidelines PDF
Policy Statement on Conflict Minerals PDF
Statement of Engagement on Public Policy Issues PDF

Committees

Audit Committee Charter PDF
Compensation and Management Development Committee Charter PDF
Corporate Governance Committee Charter PDF
Quality, Regulatory and Technology Committee Charter PDF

Committees at a Glance

  Audit Compensation and Management Development Corporate Governance Quality, Regulatory and Technology
Christopher B. Begley     Member of Compensation and Management Development Committee   Member of Quality, Regulatory and Technology Committee
Christopher Begley Retired Executive Chairman and Chief Executive Officer
Hospira, Inc.
Elected 2012

Director Since 2012

Executive Chairman of the Board of Hospira, Inc. from May 2007 until his retirement in January 2012.  Mr. Begley also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011.  Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division.  He earned a bachelor’s degree from Western Illinois University and an MBA from Northern Illinois University.  

Other Public Board Memberships

  • DeVry Education Group Inc.(Non-Executive Chair)
  • Hanger, Inc.
  • Past director and Non-Executive Chairman of The Hillshire Brands Company (until August 2014)
  • Past director of Sara Lee Corporation (until June 2012)
  • Past director and Executive Chairman of Hospira, Inc. (until January 2012)

Other Relevant Experience

  • Past director of the Advanced Medical Technology Association (“AdvaMed”), the medical device industry’s trade association
  • Past director of the National Center for Healthcare Leadership

 

Betsy J. Bernard   Member of Audit Committee   Committee Chair for Corporate Governance Committee  
Betsy J. Bernard Retired President
AT&T Corp.
Elected 2009

Director Since 2009

President of AT&T Corp. from October 2002 until her retirement in December 2003.  From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer.  Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell.  Ms. Bernard received a B.A. degree from St. Lawrence University, an MBA from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program.

Other Public Board Memberships

  • Principal Financial Group, Inc.
  • SITO Mobile Ltd. (Lead Independent Director)
  • Past director of Telular Corporation (until June 2013)

 

 

Gail K. Boudreaux   Member of Audit Committee   Member of Corporate Governance Committee  
Gail Boudreaux Chief Executive Officer and Founder
GKB Global Health, LLC

Director Since 2012

Chief Executive Officer and Founder, GKB Global Health, LLC from 2015 to present.  Ms. Boudreaux served as Chief Executive Officer of UnitedHealthcare from January 2011 to November 2014 and Executive Vice President of UnitedHealth Group from May 2008 to February 2015.  From 2005 to 2008, Ms. Boudreaux served as Executive Vice President, External Operations for Health Care Services Corporation (“HCSC”), and prior to that served as President of Blue Cross and Blue Shield of Illinois, a division of HCSC.  Before joining HCSC, Ms. Boudreaux held various positions at Aetna, including Senior Vice President, Aetna Group Insurance.  Ms. Boudreaux earned a bachelor's degree in psychology from Dartmouth College and an MBA from Columbia Business School .

Other Public Board Memberships

  • Xcel Energy Inc.
  • Novavax, Inc.

 

David C. Dvorak          
David C. Dvorak President and Chief Executive Officer
Zimmer Biomet Holdings, Inc.

Director Since 2007

David Dvorak was appointed President and Chief Executive Officer and a member of the Board of Directors of the Company in May 2007.  He championed Zimmer’s acquisition of Biomet, positioning the combined Zimmer Biomet as a global leader in musculoskeletal healthcare. 

Prior to his appointment as President and Chief Executive Officer, Mr. Dvorak served as Group President, Global Businesses and Chief Legal Officer from December 2005.  From October 2003 to December 2005, he served as Executive Vice President, Corporate Services, Chief Counsel and Secretary, as well as Chief Compliance Officer.  Mr. Dvorak joined the Company (then Zimmer) as Senior Vice President, Corporate Affairs and General Counsel in December 2001.  Before joining Zimmer, he served as Senior Vice President, General Counsel and Corporate Secretary of STERIS Corporation.  Earlier in his career, he practiced corporate law, focusing on mergers and acquisitions and on securities law.  He holds a Bachelor of Science in Business Administration (Finance) from Miami University (OH) and a J.D., magna cum laude, from Case Western Reserve University School of Law, where he was elected to the Order of the Coif.

Other Public Board Memberships

  • Past director of St. Jude Medical, Inc. (until January 2017)

Other Relevant Experience

  • Director of AdvaMed
  • Member of the Board of Trustees, Orthopaedic Research and Education Foundation
  • Past chairman of the board of AdvaMed (2012-2014)

Michael J. "Mick" Farrell     Member of Compensation and Management Development Committee Member of Corporate Governance Committee  
Michael J. Chief Executive Officer, ResMed Inc.

Director Since 2014

Chief Executive Officer of ResMed Inc. since March 2013.  Prior to that appointment, Mr. Farrell served as President – Americas for ResMed from 2011 to 2013.  He was previously Senior Vice President of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development.  Before joining ResMed in September 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company and BHP Billiton.  Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology and an MBA from the MIT Sloan School of Management.

Other Public Board Memberships

  • ResMed Inc.

Other Relevant Experience

  • Director of AdvaMed

Larry C. Glasscock   Chairman of the Board Member of Audit Committee   Member of Corporate Governance Committee  
Larry C. Glasscock Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Chairman, President and Chief Executive Officer
Anthem, Inc.

Director Since 2001; Non-Executive Chairman Since May 2013

Chairman of WellPoint, Inc. (now Anthem, Inc.) from 2005 until 2010.  Mr. Glasscock also served as President and Chief Executive Officer of WellPoint, Inc. from 2004 to 2007.  Mr. Glasscock served as Chairman, President and Chief Executive Officer of Anthem, Inc. from 2003 to 2004 and served as President and Chief Executive Officer of Anthem, Inc. from 2001 to 2003. Mr. Glasscock earned a B.B.A. from Cleveland State University.  He also completed the Commercial Bank Management Program at Columbia University.

Other Public Board Memberships

  • Simon Property Group, Inc. (Lead Independent Director)
  • Sysco Corporation
  • Past director of Sprint Nextel Corporation (until July 2013)
  • Past director and Chairman of Anthem, Inc. (until March 2010)

 

Robert A. Hagemann   Committee Chair for Audit Committee     Member of Quality, Regulatory and Technology Committee
Robert Hagemann Retired Senior Vice President and Chief Financial Officer
Quest Diagnostics Incorporated
Elected 2008

Director Since 2008

Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated until his retirement in July 2013.  Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998.  Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc.  He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young.  Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

Other Public Board Memberships

  • Graphic Packaging Holding Company
  • Ryder System, Inc.

 

Arthur J. Higgins     Committee Chair for Compensation and Management Development Committee   Member of Quality, Regulatory and Technology Committee
Arthur J. Higgins President, Chief Executive Officer and Director
Depomed, Inc.

Director Since 2007

President, Chief Executive Officer and a member of the board of directors of Depomed, Inc. since March 2017.  Consultant, Blackstone Healthcare Partners of the Blackstone Group since June 2010.  Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010.  Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004.  Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001.  He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Other Public Board Memberships

  • Depomed, Inc.
  • Ecolab Inc.
  • Past director of Endo International plc (until March 2017)
  • Past director of Resverlogix Corp. (until February 2014)

Other Relevant Experience

  • Past director of the Pharmaceutical Research and Manufacturers of America
  • Past member of the Council of the International Federation of Pharmaceutical Manufacturers and Associations
  • Past president of the European Federation of Pharmaceutical Industries and Associations

 

Michael W. Michelson     Member of Compensation and Management Development Committee   Member of Quality, Regulatory and Technology Committee
Michael Michelson Member
KKR Management LLC, the general partner of KKR & Co. L.P.

Director Since 2015

Member, KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P., since October 2009.  Before that, Mr. Michelson was a member of the limited liability company that served as the general partner of Kohlberg Kravis Roberts & Co. L.P. since 1996. He joined KKR in 1981.  Mr. Michelson has played a significant role in the development of KKR’s portfolio companies.  He began his professional career with the law firm of Latham & Watkins in Los Angeles, where he was involved in a broad corporate practice while specializing in management buyouts.  He earned an A.B. from Harvard College and a J.D. from Harvard Law School.

Other Public Board Memberships

  • Past director of HCA Holdings, Inc. (until May 2016)
  • Past director of Jazz Pharmaceuticals plc (until January 2012)

Other Relevant Experience

  • Served as a director of Biomet prior to the merger of Zimmer and Biomet

Cecil B. Pickett Ph.D.     Member of Compensation and Management Development Committee   Committee Chair for Quality, Regulatory and Technology Committee
Cecil Pickett Retired President, Research and Development
Biogen Idec Inc.
Elected 2008

Director Since 2008

President, Research and Development and a member of the board of directors of Biogen Idec Inc. from September 2006 until his retirement in October 2009.  Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute.  Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co.  Dr. Pickett received a B.S. in biology from California State University at Hayward and a Ph.D. in cell biology from University of California at Los Angeles.

Other Public Board Memberships

  • Past director of Biogen Idec (until October 2009)

Other Relevant Experience

  • Member of the Institute of Medicine of The National Academy of Sciences

.

Jeffrey K. Rhodes   Member of Audit Committee   Member of Corporate Governance Committee  
Jeffrey Rhodes Partner
TPG Capital, L.P

Director Since 2015

Partner, TPG Capital, L.P.  Mr. Rhodes is a leader of the firm’s investment activities in the healthcare services, pharmaceutical and medical device sectors.  Prior to joining TPG in 2005, Mr. Rhodes was with McKinsey & Company and Article27 LTD, a start-up software company.  He was a founding board member of the Healthcare Private Equity Association, a non-profit trade association that represents the U.S. healthcare private equity industry.  Mr. Rhodes earned a B.A. in Economics from Williams College, where he graduated summa cum laude, and an MBA from Harvard Business School, where he was a Baker Scholar.

Other Public Board Memberships

  • Surgical Care Affiliates, Inc.

Other Relevant Experience

  • Served as a director of Biomet prior to the merger of Zimmer and Biomet

Chairman of the Board = Chairman of the Board      Chair = Chair     Committee Member = Member


Print page

Email page